Reuters: Health
AstraZeneca Plc and Merck & Co Inc said on Monday their drug to treat a form of ovarian cancer improved progression-free survival in patients tested in a late-stage study.
AstraZeneca, Merck cancer treatment attains meaningful improvement in progression-free survival
AstraZeneca, Merck cancer treatment attains meaningful improvement in progression-free survival
Reuters: Health
AstraZeneca Plc and Merck & Co Inc said on Monday their drug to treat a form of ovarian cancer improved progression-free survival in patients tested in a late-stage study.
Reuters: Health
AstraZeneca Plc and Merck & Co Inc said on Monday their drug to treat a form of ovarian cancer improved progression-free survival in patients tested in a late-stage study.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment